Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating PAR-2 in rats.
Mast cell has been demonstrated to be involved in the small intestinal ischemia-reperfusion (IIR) injury, however, the precise role of tryptase released from mast cell on acute lung injury(ALI) induced by IIR remains to be elucidated, our study aimed to observe the roles of tryptase on ALI triggered by IIR and its underlying mechanism. Adult SD rats were randomized into sham-operated group, sole IIR group in which rats were subjected to 75 min superior mesenteric artery occlusion followed by 4 h reperfusion, or IIR being respectively treated with cromolyn sodium, protamine, and compound 48/80. The above agents were, respectively, administrated intravenously 5 min before reperfusion. At the end of experiment, lung tissue was obtained for assays for protein expressions of tryptase and mast cell protease 7 (MCP7) and protease-activated receptor 2 (PAR-2). Pulmonary mast cell number and levels of IL-8 were quantified. Lung histologic injury scores and lung water content were measured. IIR resulted in lung injury evidenced as significant increases in lung histological scores and lung water contents, accompanied with concomitant increases of expressions of tryptase and MCP7, and elevations in PAR-2 expressions and IL-8 levels in lungs. Stabilizing mast cell with cromolyn sodium and inhibiting tryptase with protamine significantly reduced IIR-mediated ALI and the above biochemical changes while activating mast cell with compound 48/80 further aggravated IIR-mediated ALI and the increases of above parameters. Tryptase released from mast cells mediates ALI induced by intestinal ischemia-reperfusion by activating PAR-2 to produce IL-8.
Department of Anesthesiology, The Third Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, China.
Xiaoliang
X
Gan
Dezhao
D
Liu
Pinjie
P
Huang
Wanling
W
Gao
Xinzhi
X
Chen
Ziqing
Z
Hei
D055371:Acute Lung Injury / Q000188:drug therapy / Q000473:pathology*; D000818:Animals; D004205:Cromolyn Sodium / Q000494:pharmacology; D016209:Interleukin-8 / Q000378:metabolism*; D007421:Intestine, Small / Q000098:blood supply / Q000473:pathology; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008407:Mast Cells / Q000201:enzymology; D017538:Mesenteric Artery, Superior / Q000473:pathology / Q000601:surgery; D011479:Protamines / Q000494:pharmacology; D051381:Rats; D044464:Receptor, PAR-2 / Q000096:biosynthesis / Q000378:metabolism*; D015427:Reperfusion Injury / Q000188:drug therapy / Q000473:pathology*; D053802:Tryptases / Q000378:metabolism*; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D016209:Interleukin-8; D011479:Protamines; D044464:Receptor, PAR-2; D003189:p-Methoxy-N-methylphenethylamine; C509223:Tpsab1 protein, rat; D053802:Tryptases; D004205:Cromolyn Sodium